Segment, Customer and Geographical Reporting (Tables)

6 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company’s segment information for the three months ended March 31, 2017 and 2016 is summarized below:

Results of Operations for the Three Months Ended March 31,
2017
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	5,281,000		$	4,804,000		$	-	$	10,085,000
Gross profit		1,913,000			1,875,000			-		3,788,000
GM %		36	%		39	%		-		38	%
SG&A		1,597,000			1,802,000			392,000		3,791,000
Operating income (loss)		316,000			73,000			(392,000)		(3,000)
Depreciation and amortization		237,000			73,000			3,000		313,000
Capital expenditures		103,000			34,000			44,000		181,000
Intangibles, net		465,000			213,000			379,000		1,057,000
Goodwill		899,000			4,939,000			-		5,838,000
Total assets	$	19,705,000		$	7,477,000		$	794,000	$	27,976,000

Results of Operations for the Three Months Ended March 31,
2016
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	6,428,000		$	4,868,000		$	-	$	11,296,000
Gross profit		2,208,000			1,870,000			-		4,078,000
GM %		34	%		38	%		-		36	%
SG&A		1,882,000			1,800,000			355,000		4,037,000
Operating income (loss)		326,000			70,000			(355,000)		41,000
Depreciation and amortization		225,000			85,000			17,000		327,000
Capital expenditures		329,000			30,000			20,000		379,000
Intangibles, net		608,000			247,000			301,000		1,156,000
Goodwill		1,109,000			4,939,000			-		6,048,000
Total assets	$	17,653,000		$	8,502,000		$	571,000	$	26,726,000

The Company’s segment information for the six months ended March 31, 2017 and 2016 is summarized below:

Results of Operations for the Six Months Ended March 31,
2017
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	9,686,000		$	9,542,000		$	-	$	19,228,000
Gross profit		3,487,000			3,826,000			-		7,313,000
GM %		36	%		40	%		-		38	%
SG&A		2,924,000			3,542,000			773,000		7,239,000
Gain on sale of assets		-			-			-		-
Operating income (loss)		563,000			284,000			(773,000)		74,000
Depreciation and amortization		471,000			147,000			6,000		624,000
Capital expenditures		194,000			34,000			64,000		292,000
Intangibles, net		465,000			213,000			379,000		1,057,000
Goodwill		899,000			4,939,000			-		5,838,000
Total assets	$	19,705,000		$	7,477,000		$	794,000	$	27,976,000

Results of Operations for the Six Months Ended March 31,
2016
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	12,635,000		$	9,858,000		$	-	$	22,493,000
Gross profit		4,318,000			3,724,000			-		8,042,000
GM %		34	%		38	%		-		36	%
SG&A		3,634,000			3,506,000			703,000		7,843,000
Gain on sale of assets		4,000			-			-		4,000
Operating income (loss)		688,000			218,000			(703,000)		203,000
Depreciation and amortization		454,000			164,000			34,000		652,000
Capital expenditures		894,000			37,000			51,000		982,000
Intangibles, net		608,000			247,000			301,000		1,156,000
Goodwill		1,109,000			4,939,000			-		6,048,000
Total assets	$	17,653,000		$	8,502,000		$	571,000	$	26,726,000

Schedule Of Segment Revenue By Geographical Location [Table Text Block]

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2017 and 2016 are as follows:

	Three Months Ended					Three Months Ended
	March 31, 2017					March 31, 2016
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	7,931,000		79	%	$	8,226,000		73	%
Europe		1,212,000		12	%		2,452,000		22	%
Other		942,000		9	%		618,000		5	%
	$	10,085,000		100	%	$	11,296,000		100	%

Revenue by geographic location in total and as a percentage of total revenue, for the six months ended March 31, 2016 and 2015 are as follows:

	Six Months Ended					Six Months Ended
	March 31, 2017					March 31, 2016
Geographic Location	Revenue		% of Total			Revenue		% of Total
United States	$	15,120,000		79	%	$	16,455,000		73	%
Europe		2,299,000		12	%		4,493,000		20	%
Other		1,809,000		9	%		1,545,000		7	%
	$	19,228,000		100	%	$	22,493,000		100	%